V. S. Shirinsky

647 total citations
34 papers, 282 citations indexed

About

V. S. Shirinsky is a scholar working on Rheumatology, Pharmacology and Molecular Biology. According to data from OpenAlex, V. S. Shirinsky has authored 34 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Rheumatology, 13 papers in Pharmacology and 10 papers in Molecular Biology. Recurrent topics in V. S. Shirinsky's work include Osteoarthritis Treatment and Mechanisms (14 papers), Inflammatory mediators and NSAID effects (13 papers) and Rheumatoid Arthritis Research and Therapies (9 papers). V. S. Shirinsky is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (14 papers), Inflammatory mediators and NSAID effects (13 papers) and Rheumatoid Arthritis Research and Therapies (9 papers). V. S. Shirinsky collaborates with scholars based in Russia, France and Canada. V. S. Shirinsky's co-authors include I. V. Shirinsky, Uxía Nogueira-Recalde, Martin Lotz, Francisco J. Blanco, Paul D. Robbins, B. Caramés, Diego Grassi, Eduardo Domínguez, Marı́a Isabel Loza and Kozlov Va and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Arthritis Research & Therapy.

In The Last Decade

V. S. Shirinsky

25 papers receiving 276 citations

Peers

Countries citing papers authored by V. S. Shirinsky

Since Specialization

Citations

This map shows the geographic impact of V. S. Shirinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. S. Shirinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. S. Shirinsky more than expected).

Fields of papers citing papers by V. S. Shirinsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. S. Shirinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. S. Shirinsky. The network helps show where V. S. Shirinsky may publish in the future.

Co-authorship network of co-authors of V. S. Shirinsky

This figure shows the co-authorship network connecting the top 25 collaborators of V. S. Shirinsky. A scholar is included among the top collaborators of V. S. Shirinsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. S. Shirinsky. V. S. Shirinsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and safety of curcumin in patients with metabolic phenotype of osteoarthritis: A pilot study 2023 ·SHILAP Revista de lepidopterología ·I. V. Shirinsky, V. S. Shirinsky, (unknown)	0
2	Comparative analysis of the expression of the soluble IL-7 receptor in patients with arthropathy 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), I. V. Shirinsky, V. S. Shirinsky, (unknown)	0
3	Serum Cytokines as Biomarkers in Heart Failure with Preserved Ejection Fraction and Sleep Apnea: A Prospective Cohort Study 2023 ·Life ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), V. S. Shirinsky, I. V. Shirinsky	0
4	Osteoimmunology: an interdisciplinary approach to studying the relationships between immune and bone cells 2022 ·SHILAP Revista de lepidopterología ·V. S. Shirinsky, I. V. Shirinsky	1
5	Tear cytokines as potential biomarkers in non-infectious uveitis: post hoc analysis of a randomised clinical trial 2020 ·Graefe s Archive for Clinical and Experimental Ophthalmology ·I. V. Shirinsky, (unknown), (unknown), V. S. Shirinsky	3
6	Combination treatment of patients with metabolic phenotype of osteoarthritis: an exploratory study 2020 ·SHILAP Revista de lepidopterología ·V. S. Shirinsky, (unknown), (unknown), I. V. Shirinsky	0
7	Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy 2019 ·EBioMedicine ·Uxía Nogueira-Recalde, (unknown), Francisco J. Blanco, Marı́a Isabel Loza, Diego Grassi, V. S. Shirinsky, I. V. Shirinsky, Martin Lotz, Paul D. Robbins, Eduardo Domínguez, B. Caramés	112
8	H1-antihistamines are associated with lower prevalence of radiographic knee osteoarthritis: a cross-sectional analysis of the Osteoarthritis Initiative data 2018 ·Arthritis Research & Therapy ·I. V. Shirinsky, V. S. Shirinsky	20
9	Effects of medication-treated diabetes on incidence and progression of knee osteoarthritis: a longitudinal analysis of the Osteoarthritis Initiative data 2017 ·Rheumatology International ·I. V. Shirinsky, V. S. Shirinsky	18
10	CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, A PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY 2017 ·Medical Immunology (Russia) ·V. S. Shirinsky, (unknown), (unknown), I. V. Shirinsky	1
11	DIABETES-ASSOCIATED OSTEOARTHRITIS: A SYNTROPY? 2016 ·Medical Immunology (Russia) ·(unknown), V. S. Shirinsky, I. V. Shirinsky	4
12	CULTURES OF FIBROBLAST-LIKE SYNOVIAL CELLS FROM PATIENTS WITH RHEUMATOID ARTHRITIS: PROPERTIES AND OPPORTUNITIES 2016 ·Medical Immunology (Russia) ·Maren Schneider, V. S. Shirinsky, I. V. Shirinsky	0
13	FRI0201 Efficacyand Safety of Simvastatinin Uveitis Associated with HLAB27 and/or Rheumatic Diseases: A Randomized, Open-Label Study 2015 ·Annals of the Rheumatic Diseases ·(unknown), I. V. Shirinsky, V. S. Shirinsky	1
14	EFFECTS OF STATINS UPON ANTIGEN-SPECIFIC LYMPHOCYTE ACTIVATION IN PATIENTS WITH RHEUMATOID ARTHRITIS: AN IN VITRO STUDY 2014 ·Medical Immunology (Russia) ·I. V. Shirinsky, V. S. Shirinsky	0
15	EFFICACY AND SAFETY OF SIMVASTATIN IN RHEUMATOID ARTHRITIS: AN OPEN-LABEL, CONTROLLED STUDY 2014 ·Medical Immunology (Russia) ·I. V. Shirinsky, (unknown), V. S. Shirinsky, Kozlov Va	0
16	Treatment of erosive osteoarthritis with peroxisome proliferator-activated receptor alpha agonist fenofibrate: a pilot study 2013 ·Rheumatology International ·I. V. Shirinsky, V. S. Shirinsky	20
17	OP0026 Diabetes Effects on Pain and Physical Function in Incidence and Progression Subcohorts of the Osteoarthritis Initiative: A 5-Year Longitudinal Data Analysis 2013 ·Annals of the Rheumatic Diseases ·I. V. Shirinsky, V. S. Shirinsky	1
18	The effects of fenofibrate on inflammation and cardiovascular markers in patients with active rheumatoid arthritis: a pilot study 2012 ·Rheumatology International ·I. V. Shirinsky, (unknown), (unknown), V. S. Shirinsky	25
19	Efficacy and Safety of CH-1504, a Metabolically Stable Antifolate, in Patients with Active Rheumatoid Arthritis: Results of a Phase II Multicenter Randomized Study 2011 ·The Journal of Rheumatology ·Edward Keystone, V. S. Shirinsky, Lee S. Simon, Simon C.J. Pedder, L. Arthur Hewitt, (unknown)	4
20	Changes in disease activity, cytokine production, and proliferation of peripheral blood mononuclear cells in patients with rheumatoid arthritis after simvastatin treatment 2008 ·Scandinavian Journal of Rheumatology ·I. V. Shirinsky, (unknown), (unknown), Kozlov Va, V. S. Shirinsky	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact